Evaluating the advantages and limitations of viral (AAV, lentivirus) vs. non-viral (LNP, electroporation) delivery systems.

 Optimizing delivery strategies for enhanced precision, durability, and reduced off-target effects.

 Addressing production challenges, regulatory hurdles, and cost-effectiveness for clinical and commercial applications.